This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rossi, E. Articles by Costa, M. Search for Related Content PubMed PubMed Citation Articles by Rossi, E. Articles by Costa, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Risk Pregnancy Social Bookmarking                         What's this?

Fish Oil Derivatives as a Prophylaxis of Recurrent Miscarriage Associated with Antiphospholipid Antibodies (APL) : a Pilot Study

Department of Haematology I, Ospedale S. Martino, University of Genoa, Genoa, Italy

Mauro Costa

department of Obstetrics and Gynaecology, University of Genoa, Genoa, Italy

Since 1989, 22 patients with persistent antiphospholipid syndrome (PAPS) associated with recurrent miscarriage (defined as three or more miscarriages) were treated with fish oil, equivalent to 5.1 g eicosapetaenoic acid (EPA) and docosahexaenoic acid (DHA) at a ratio of 1.5 EPA to DHA. Twenty-two patients had 23 pregnancies (one patient had two pregnancies) over a period of 3 years. There was only one intrauterine fetal death at the 27th week associated with pre-eclampsia. Twenty-one pregnancies, 19 of which ended after the 37th week, produced a baby. Two pregnancies ended with cesarean section for pre-eclampsia at 30th and 35th week of gestation and one is ongoing at 32nd week. All babies are well. The weight at birth of babies delivered at term was always >2500 g. These encouraging results favour a therapeutic role, without any adverse reaction, of fish oil to prevent recurrent miscarriage in PAPS.

Key Words: Fish oil • Persistent antiphospholipid syndrome • Recurrent miscarriage

Lupus, Vol. 2, No. 5, 319-323 (1993)
DOI: 10.1177/096120339300200508


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				U Mahadevan Fertility and pregnancy in the patient with inflammatory bowel disease. Gut, August 1, 2006; 55(8): 1198 - 1206. [Full Text] [PDF]

				C. L Jensen Effects of n-3 fatty acids during pregnancy and lactation Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1452 - 1457S. [Abstract] [Full Text] [PDF]

				M McFadyen, J Farquharson, and F Cockburn Maternal and umbilical cord erythrocyte omega-3 and omega-6 fatty acids and haemorheology in singleton and twin pregnancies Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F134 - F138. [Abstract] [Full Text] [PDF]

				A Leiba, H Amital, M E Gershwin, and Y Shoenfeld Diet and lupus Lupus, March 1, 2001; 10(3): 246 - 248. [Abstract] [PDF]